PHARMAKING CO LTD has a total of 22 patent applications. Its first patent ever was published in 2004. It filed its patents most often in Republic of Korea, China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, foods and drinks and medical technology are TESORX PHARMA LLC, HEBEI JUNLIN PHARMACEUTICAL CO LTD and FORTE IQ B V.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 7 | |
#2 | China | 4 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | United States | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 3 | |
#6 | Brazil | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks | |
#3 | Medical technology | |
#4 | Organic fine chemistry | |
#5 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Special foods | |
#4 | Syringes | |
#5 | Foods | |
#6 | Nanostructure applications | |
#7 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Kwak Wie Jong | 17 |
#2 | Kim Soon Bae | 17 |
#3 | Kim Wan Bae | 17 |
#4 | Kim Gwang Soon | 17 |
#5 | Jeon Sun Duck | 9 |
#6 | Yoon Hyung Young | 9 |
#7 | Bang Sung Hye | 8 |
#8 | Hahm Ki Baik | 4 |
#9 | Jang Young Pyo | 4 |
#10 | Kim Eun Hee | 4 |
Publication | Filing date | Title |
---|---|---|
KR20150101148A | Nano-particulate Montelukast And Manufacturing Method For Thereof | |
KR20140023659A | Composition comprising s-allyl-l-cysteine for preventing or treating eye disease and medicinal products | |
KR101320945B1 | Composition comprising s-allyl-l-cysteine for preventing or treating colitis and medicinal products | |
KR20110064212A | Anti-inflammatory pharmaceutical composition comprising the extracts from broussonetia papyrifera and lonicera japonica | |
KR20110049166A | Sustained release preparation comprising nicametate and preparation method thereof | |
KR20110032641A | Composition comprising s-allyl-l-cysteine for preventing or treating gastrointestinal disorders | |
KR20060020095A | Allylthiopyridazine derivative for hepatocarcinoma and hepatism |